New test in Asper Metabolic Disorders menu

Our latest release is a panel of Congenital Disorders of Glycolysation targeting pathogenic variants in 49 clinically relevant genes. List of genes with more detailed information is available  www.asperbio.com/congenital-disorders-of-glycolysation/